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Abstract
Motivation: State-of-the-art biomedical named entity recognition (BioNER) systems often require
handcrafted features specific to each entity type, such as genes, chemicals and diseases. Although recent
studies explored using neural network models for BioNER to free experts from manual feature engineering,
the performance remains limited by the available training data for each entity type.
Results: We propose a multi-task learning framework for BioNER to collectively use the training data of
different types of entities and improve the performance on each of them. In experiments on 15 benchmark
BioNER datasets, our multi-task model achieves substantially better performance compared with state-
of-the-art BioNER systems and baseline neural sequence labeling models. Further analysis shows that
the large performance gains come from sharing character- and word-level information among relevant
biomedical entities across differently labeled corpora.
Availability: Our source code is available at https://github.com/yuzhimanhua/lm-lstm-crf.
Contact: xwang174@illinois.edu, xiangren@usc.edu.
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Biomedical named entity recognition (BioNER) is one of the most
fundamental task in biomedical text mining that aims to automatically
recognize and classify biomedical entities (e.g., genes, proteins, chemicals
and diseases) from text. BioNER can be used to identify new gene names
from text (Smith et al., 2008). It also serves as a primitive step of many
downstream applications, such as relation extraction (Cokol et al., 2005)
and knowledge base completion (Szklarczyk et al., 2017; Wei et al., 2013;
Xie et al., 2013; Szklarczyk et al., 2015).
BioNER is typically formulated as a sequence labeling problem whose
goal is to assign a label to each word in a sentence. State-of-the-art
BioNER systems often require handcrafted features (e.g., capitalization,
prefix and suffix) to be specifically designed for each entity type (Ando,
2007; Leaman and Lu, 2016; Zhou and Su, 2004; Lu et al., 2015). This
feature generation process takes the majority of time and cost in developing
a BioNER system (Leser and Hakenberg, 2005), and leads to highly
specialized systems that cannot be directly used to recognize new types
of entities. The accuracy of the resulting BioNER tools remains a limiting
factor in the performance of biomedical text mining pipelines (Huang and
Lu, 2015).
Recent NER studies consider neural network models to automatically
generate quality features (Chiu and Nichols, 2016; Ma and Hovy, 2016;
Lample et al., 2016; Liu et al., 2018). Crichton et al. took each word
token and its surrounding context words as input into a convolutional
neural network (CNN). Habibi et al. adopted the model from Lample
et al. and used word embeddings as input into a bidirectional long short-
term memory-conditional random field (BiLSTM-CRF) model. These
neural network models free experts from manual feature engineering.
However, these models have millions of parameters and require very large
datasets to reliably estimate the parameters. This poses a major challenge
for biomedicine, where datasets of this scale are expensive and slow
to create and thus neural network models cannot realize their potential
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performance to the fullest (Camacho et al., 2018). Although neural network
models can outperform traditional sequence labeling models (e.g., CRF
models (Lafferty et al., 2001)), they are still outperfomed by handcrafted
feature-based systems in multiple domains (Crichton et al., 2017).
One direction to address the above challenge is to use the labeled data
of different entity types to augment the training signals for each of them, as
information like word semantics and grammatical structure may be shared
across different datasets. However, simply combining all datasets and
training one single model over multiple entity types can introduce many
false negatives because each dataset is typically specifically annotated for
one or only a few entity types. For example, combining dataset A for
gene recognition and dataset B for chemical recognition will result in
missing chemical entity labels in dataset A and missing gene entity labels
in dataset B. Multi-task learning (MTL) (Collobert and Weston, 2008;
Søgaard and Goldberg, 2016) offers a solution to this issue by collectively
training a model on several related tasks, so that each task benefits model
learning in other tasks without introducing additional errors. MTL has been
successfully applied in natural language processing (Collobert and Weston,
2008), speech recognition (Deng et al., 2013), computer vision (Girshick,
2015) and drug discovery (Ramsundar et al., 2015). But MTL is less
commonly used and has seen limited success in BioNER so far. Crichton
et al. explored MTL with a CNN model for BioNER. However, Crichton
et al. only considers word-level features as input, ignoring character-
level lexical information which are often crucial for modeling biomedical
entities (e.g. -ase could be an important subword feature for gene/protein
entity recognition). As a result, their best performing multi-task CNN
model does not outperform state-of-the-art systems that use on handcrafted
features (Crichton et al., 2017).
In this paper, we propose a new multi-task learning framework using
char-level neural models for BioNER. The proposed framework, despite
being simple and not requiring any feature engineering, achieves excellent
benchmark performance. Our multi-task model is built upon a single-
task neural network model (Liu et al., 2018). In particular, we consider
a BiLSTM-CRF model with an additional context-dependent BiLSTM
layer for modeling character sequences. A prominent advantage of our
multi-task model is that inputs from different datasets can efficiently share
both character- and word-level representations, by reusing parameters in
the corresponding BiLSTM units. We compare the proposed multi-task
model with state-of-the-art BioNER systems and baseline neural network
models on 15 benchmark BioNER datasets and observe substantially better
performance. We further show through detailed experimental analysis on 5
datasets that the proposed approach adds marginal computational overhead
and outperforms strong baseline neural models that do not consider multi-
task learning, suggesting that multi-task learning plays an important role in
its success. Altogether, this work introduces a new text-mining approach
that can help scientists exploit knowledge buried in biomedical literature
in a systematic and unbiased way.
2 Background
2.1 NER problem definition
Let Φ denote the set of labels indicating whether a word is part of a specific
entity type or not. Given a sequence of wordsw = {w1, w2, ..., wn}, the
output is a sequence of labelsy = {y1, y2, ..., yn}, yi ∈ Φ. For example,
given a sentence “.... including the RING1 ...", the output should be “... O
O S-GENE ..." in which “O" indicates a non-entity type and “S-GENE"
indicates a single-token GENE type.
2.2 Long Short-Term Memory (LSTM)
Long short-term memory neural network is a specific type of recurrent
neural network that models dependencies between elements in a sequence
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Fig. 1. Architecture of long short-term memory neural network.
through recurrent connections (Fig. 1). The input to an LSTM network
is a sequence of vectors X = {x1,x2, ...,xT }, where vector xi
is a representation vector of a word in the input sentence. The output
is a sequence of vectors H = {h1,h2, ...,hT }, where hi is a
hidden state vector. At step t of the recurrent calculation, the network
takes xt, ct−1,ht−1 as inputs and produces ct,ht via the following
intermediate calculations:
it = σ(W
ixt +U
iht−1 + bi)
f t = σ(W
fxt +U
fht−1 + bf )
ot = σ(W
oxt +U
oht−1 + bo)
gt = tanh(W
gxt +U
ght−1 + bg)
ct = f t  ct−1 + it  gt
ht = ot  tanh(ct),
where σ(·) and tanh(·) denote element-wise sigmoid and hyperbolic
tangent functions, respectively, anddenotes element-wise multiplication.
The it, f t and ot are referred to as input, forget, and output gates,
respectively. The gt and ct are intermediate calculation steps. At t = 1,
h0 and c0 are initialized to zero vectors. The trainable parameters are
W j ,Uj and bj for j ∈ {i, f, o, g}.
The LSTM architecture described above can only process the input
in one direction. The bi-directional long short-term memory (BiLSTM)
model improves the LSTM by feeding the input to the LSTM network
twice, once in the original direction and once in the reversed direction.
Outputs from both directions are concatenated to represent the final output.
This design allows for detection of dependencies from both previous and
subsequent words in a sequence.
2.3 Bi-directional Long Short-Term Memory-Conditional
Random Field (BiLSTM-CRF)
A naive way of applying the BiLSTM network to sequence labeling
is to use the output hidden state vectors to make independent tagging
decisions. However, in many sequence labeling tasks such as BioNER,
it is useful to also model the dependencies across output tags. The
BiLSTM-CRF network adds a conditional random field (CRF) layer on
top of a BiLSTM network. This BiLSTM-CRF network takes the input
sequence X = {x1,x2, ...,xn} to predict an output label sequence
y = {y1, y2, ..., yn}. A score is defined as:
s(X,y) =
n∑
i=0
Ayi,yi+1 +
n∑
i=1
P i,yi ,
whereP is an n×k matrix of the output from the BiLSTM layer, n is the
sequence length, k is the number of distinct labels,A is a (k+2)×(k+2)
transition matrix and Ai,j represents the transition probability from the
i-th label to the j-th label. Note that two additional labels <start> and
<end> are used to represent the start and end of a sentence, respectively.
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Fig. 2. Architecture of a single-task neural network. The input is a sentence from biomedical literature. Rectangles denote character and word embeddings; empty round rectangles denote
the first character-level BiLSTM; shaded round rectangles denote the second word-level BiLSTM; pentagons denote the concatenation units. The tags on the top, e.g., ’O’, ’S-GENE’, are
the output of the final CRF layer, which are the entity labels we get for each word in the sentence.
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Fig. 3. Three multi-task learning neural network models. The empty circles denote the character embeddings. The empty round rectangles denote the character-level BiLSTM. The shaded
circles denote the word-level embeddings. The shaded round rectangles denote the word-level BiLSTM. The squares denote the CRF layer. (a) MTM-C: multi-task learning neural network
with a shared character layer and a task-specific word layer, (b): MTM-W: multi-task learning neural network with a task-specific character layer and a shared word layer, (c) MTM-CW:
multi-task learning neural network with shared character and word layers.
We further define Y X as all possible sequence labels given the input
sequence X . The training process maximizes the log-probability of the
label sequence y given the input sequence X:
log(p(y|X)) = log e
s(X,y)∑
y′∈YX e
s(X,y′)
. (1)
A three-layer BiLSTM-CRF architecture is employed by Lample
et al. and Habibi et al. to jointly model the word and the character
sequences in the input sentence. In this architecture, the first BiLSTM
layer takes character embedding sequence of each word as input, and
produces a character-level representation vector for this word as output.
This character-level vector is then concatenated with a word embedding
vector, and fed into a second BiLSTM layer. Lastly, a CRF layer takes the
output vectors from the second BiLSTM layer, and outputs the best tag
sequence by maximizing the log-probability in Equation 1.
In practice, the character embedding vectors are randomly initialized
and co-trained during the model training process. The word embedding
vectors are retrieved directly from a pre-trained word embedding lookup
table. The classical Viterbi algorithm is used to infer the final labels for
the CRF model. The three-layer BiLSTM-CRF model is a differentiable
neural network architecture that can be trained by backpropagation.
3 Deep multi-task learning for BioNER
3.1 Single-task model (STM)
The vanilla BiLSTM-CRF model can learn high-quality representations
for words that appeared in the training dataset. However, it often fails
to generalize to out-of-vocabulary (OOV) words (i.e., words that did not
appear in the training dataset) because they don’t have a pre-trained word
embedding. These OOV words are common in biomedical text (67.21%
OOV words of the datasets in Table 1). Therefore, for the baseline single-
task BioNER model, we use a neural network architecture that better
handles OOV words. As shown in Fig. 2, our single-task model consists
of three layers. In the first layer, a BiLSTM network is used to model
the character sequence of the input sentence. We use character embedding
vectors as input to the network. Hidden state vectors at the word boundaries
of this character-level BiLSTM are then selected and concatenated with
word embedding vectors to form word representations. Next, these word
representation vectors are fed into a word-level BiLSTM layer (i.e., the
upper BiLSTM layer in Fig. 2). Lastly, output of this word-level BiLSTM
is fed into the a CRF layer for label prediction. Compared to the vanilla
BiLSTM-CRF model, a major advantage of this model is that it can infer
the meaning of an out-of-vocabulary word from its character sequence and
other characters around it. For example, the model is now able to infer that
“RING2” likely represents a gene symbol, even though then network may
have only seen the word “RING1” during training.
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3.2 Multi-task models (MTMs)
An important characteristic of the BioNER task is the limited availability
of supervised training data. We propose a multi-task learning approach
to address this problem by training different BioNER models on datasets
with different entity types while sharing parameters across these models.
We hypothesize that the proposed approach can make more efficient use
of the data and encourage the models to learn representations of words and
characters (which are shared between multiple corpora) in a more effective
and generalized way.
We give a formal definition of the multi-task setting as the following.
Given m datasets, for i ∈ {1, ...,m}, each dataset Di consists of ni
training samples, i.e., Di = {wij , yij}nij=1. We denote the training
matrix for each dataset as Xi = {xi1, ...,xini} (Xi is the feature
representation of the input word sequence wij ) and the labels for each
dataset as yi = {yi1, ..., yini}. The model parameters include the word-
level BiLSTM parameters (θwi ), the character-level BiLSTM parameters
(θci ) and the output CRF parameters (θ
o
i ). A multi-task model therefore
consists of m different models, each trained on a separate dataset, while
sharing part of the model parameters across datasets. The loss function L
of the multi-task model is:
L =
m∑
i=1
λiLi =
m∑
i=1
λi log(Pθwi ,θ
c
i ,θ
o
i
(yi|Xi)).
The log-likelihood term is shown in Equation 1 and λi is a positive hyper-
parameter that controls the contribution of each dataset. We observed that
our multi-task model is able to achieve very competitive performance with
λi = 1 on all datasets that we evaluated on and therefore use this value
in our experiments. However, we believe that the performance can be
improved with further tuned λi values.
We propose three different multi-task models, as illustrated in Fig.
3. These three models differ in which part of the model parameters
(θwi , θ
c
i , θ
o
i ) are shared across multiple datasets:
MTM-C In this model, θci = θ
c are shared among different tasks. All
datasets are iteratively used to train the model. When a dataset is used,
the parameters updated during the training are θc and θwi . The detailed
architecture of this multi-task model is shown in Fig. 3(a).
MTM-W In this model, θwi = θ
w are shared among different tasks. When
a dataset is used, the parameters updated during the training are θw and θci .
The detailed architecture of this multi-task model is shown in Fig. 3(b).
MTM-CW In this model, θci = θ
c and θwi = θ
w are shared among
different tasks. Each dataset has its specific θoi for label prediction. MTM-
CW shared the most information across tasks compared with the other
two multi-task models. It enables sharing both character- and word-
level information between different biomedical entities, while the other
two models only enable sharing part of the information. The detailed
architecture of this multi-task model is shown in Fig. 3(c).
4 Experimental setup
4.1 Datasets
We test our method on the same 15 datasets used by Crichton et al., and
find our model achieves substantially better performance on 14 of them
compared with baseline neural network models. Due to space limit, here we
report detailed results of the multi-task model on 5 main datasets (Table 1),
which altogether cover major biomedical entity types (e.g., genes, proteins,
chemicals, diseases). We also include full results on all the 15 datasets in
Supplementary Material: Performance comparison on 15 datasets. The
performance of the multi-task model is slightly different when trained on
5 datasets compared with trained on 15 datasets (shown in Supplementary
Table 1. Biomedical NER datasets used in the experiments.
Dataset Size Entity types and counts
BC2GM 20,000 sentences Gene/Protein (24,583)
BC4CHEMD 10,000 abstracts Chemical (84,310)
BC5CDR 1,500 articles Chemical (15,935), Disease (12,852)
NCBI-Disease 793 abstracts Disease (6,881)
JNLPBA 2,404 abstracts
Gene/Protein (35,336),
Cell Line (4,330), DNA (10,589),
Cell Type (8,649), RNA (1,069)
Material: Performance comparison on 15 datasets), as the MTL model
has access to more data. In our experiments, we follow the experiment
setup of Crichton et al. and divide each dataset into training, development
and test sets. We use training and development sets to train the final model.
All datasets are publicly available.1 As part of preprocessing, word labels
are encoded using an IOBES scheme. In this scheme, for example, a word
describing a gene entity is tagged with “B-Gene” if it is at the beginning
of the entity, “I-Gene” if it is in the middle of the entity, and “E-Gene”
if it is at the end of the entity. Single-word gene entities are tagged with
“S-Gene”. All other words not describing entities of interest are tagged as
‘O’. Next, we briefly describe the 5 main datasets and their corresponding
state-of-the-art BioNER systems.
BC2GM The state-of-the-art system reported for the BioCreative II gene
mention recognition task adopts semi-supervised learning method with
alternating structure optimization (Ando, 2007).
BC4CHEMD The state-of-the-art system reported for the BioCreative IV
chemical entity mention recognition task is the CHEMDNER system (Lu
et al., 2015), which is based on mixed conditional random fields with
Brown clustering of words.
BC5CDR The state-of-the-art system reported for the most recent
BioCreative V chemical and disease mention recognition task is the
TaggerOne system (Leaman and Lu, 2016), which uses a semi-Markov
model for joint entity recognition and normalization.
NCBI-Disease The NCBI disease dataset was initially introduced for
disease name recognition and normalization. It has been widely used for
a lot of applications. The state-of-the-art system on this dataset is also the
TaggerOne system (Leaman and Lu, 2016).
JNLPBA The state-of-the-art system (Zhou and Su, 2004) for the 2004
JNLPBA shared task on biomedical entity (gene/protein, DNA, RNA, cell
line, cell type) recognition uses a hidden markov model (HMM). Although
this task and the model is a bit old compared with the others, it still remains
a competitive benchmark method for comparison.
4.2 Evaluation metrics
We report the performance of all the compared methods on the test set.
We deem each predicted entity as correct only if both the entity boundary
and entity types are the same as the ground-truth annotation (i.e., exact
match). Then we calculate the precision, recall and F1 scores on all datasets
and macro-averaged F1 scores on all entity types. For error analysis, we
compare the ratios of false positive (FP) and false negative (FN) labels
in the single-task and the multi-task models and include the results in
Supplementary Material: Error analysis.
The test set of the BC2GM dataset is constructed slightly differently
compared to the test sets of other datasets. BC2GM additionally provides
a list of alternative answers for each entity in the test set. A predicted
1 All datasets can be downloaded from:
https://github.com/cambridgeltl/MTL-Bioinformatics-2016.
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Table 2. Performance and average training time of the baseline neural network models and the proposed MTM-CW model. Bold: best scores, *: significantly worse
than the MTM-CW model (p ≤ 0.05), **: significantly worse than the MTM-CW model (p ≤ 0.01). The details of dataset benchmark systems and evaluation
methods are described in Section 4.1 and 4.2, respectively.
Dataset
Benchmark
Crichton et al.
Lample et al.
Habibi et al.
Ma and Hovy STM MTM-CW
BC2GM
(Exact)
Precision - - 81.57±0.26∗ 79.09±0.63∗∗ 81.11±0.33∗ 82.10±0.04
Recall - - 79.48±0.27 77.87±0.53∗∗ 78.91±0.40∗∗ 79.42±0.01
F1 - 73.17∗∗ 80.51±0.09 78.48±0.31∗∗ 80.00±0.15∗ 80.74±0.04
BC2GM
(Alternative)
Precision 88.48 - 87.27±0.41∗∗ 83.50±0.37∗∗ 88.21±0.28∗ 89.45±0.32
Recall 85.97∗∗ - 87.84±0.19 87.13±0.17∗ 87.43±0.18∗ 88.67±0.37
F1 87.21∗∗ 84.41∗∗ 87.55±0.10∗ 85.27±0.11∗∗ 87.82±0.30∗ 89.06±0.32
BC4CHEMD
Precision 88.73∗∗ - 89.68±0.22∗ 90.83±0.53 90.53±0.72∗ 91.30±0.08
Recall 87.41 - 85.87±0.16∗ 83.19±0.20∗∗ 87.04±0.50 87.53±0.11
F1 88.06∗ 83.02∗∗ 87.74±0.05∗∗ 86.84±0.07∗∗ 88.75±0.20 89.37±0.07
BC5CDR
Precision 89.21 - 87.60±0.08∗∗ 89.16±0.03 88.84±0.08 89.10±0.11
Recall 84.45∗∗ - 86.25±0.07∗∗ 84.28±0.02∗∗ 85.16±0.05∗∗ 88.47±0.04
F1 86.76∗∗ 83.90∗∗ 86.92±0.06∗∗ 86.65±0.06∗∗ 86.96±0.00∗∗ 88.78±0.12
NCBI-Disease
Precision 85.10 - 86.11±0.33 86.89±0.34 84.95±0.41 85.86±0.90
Recall 80.80∗∗ - 85.49±0.93 78.75±0.16∗∗ 82.92±0.31∗ 86.42±0.44
F1 82.90∗∗ 80.37∗∗ 85.80±0.16 82.62±0.29∗∗ 83.92±0.18∗ 86.14±0.31
JNLPBA
Precision 69.42∗∗ - 71.35±0.05 70.28±0.03∗ 69.60±0.07∗∗ 70.91±0.02
Recall 75.99 - 75.74±0.07 75.26±0.41 74.95±0.24∗ 76.34±0.23
F1 72.55∗∗ 70.09∗∗ 73.48±0.03 72.68±0.21∗ 72.17±0.13∗∗ 73.52±0.03
Training time (s/sent.) - - 1.59 0.95 0.71 0.75
entity is deemed correct as long as it matches the ground truth or one of
the alternative answers. We refer to this measurement as alternative match
and report scores under both exact match and alternative match for the
BC2GM dataset.
4.3 Pre-trained word embeddings
We initialize the word embedding matrix with pre-trained word vectors
from Pyysalo et al., 2013 in all experiments.2 These word embeddings
are trained using a skip-gram model, as described in Mikolov et al., 2013.
These word vectors are trained on three different datasets: (1) abstracts
from the PubMed database, (2) abstracts from the PubMed database
together with full-text articles from the PubMed Central (PMC), and (3) the
entire Pubmed database of abstracts and full-text articles together with the
Wikipedia corpus. We found the third set of word vectors lead to best results
on development set and therefore used it for the model development. We
provide a full comparison of different word embeddings in Supplementary
Material: Performance of Word Embeddings. In all experiments, we
replace rare words (i.e., words with a frequency of less than 5) with a special
<UNK> token, whose embedding is randomly initialized and fine-tuned
during model training.
4.4 Training details
All the neural network models are trained on one GeForce GTX 1080 GPU.
To train our neural models, we use a learning rate of 0.01 with a decay
rate of 0.05 applied to every epoch of training. The dimensions of word
and character embedding vectors are set to be 200 and 30, respectively
(Liu et al., 2018). We adopted 200 (best performance among 100, 200
and 300) for both character- and word-level BiLSTM layers. Note that Liu
et al. considers advanced strategies, such as highway structures, to further
improve performance. We did not observe any significant performance
boost with these advanced strategies, thus do not adopt these strategies in
this work. The performance of the model variations with these advanced
strategies can be found in Supplementary Material: Performance of Model
2 The pre-trained word vectors can be download from:
http://bio.nlplab.org/.
Variations. To train the baseline neural network models, we use the default
parameter settings as used in their paper (Lample et al., 2016; Habibi et al.,
2017; Ma and Hovy, 2016) because we found the default parameters also
lead to almost optimal performance on the development set.
5 Results
5.1 Performance comparison on benchmark datasets
We compare the proposed single-task (Section 3.1) and multi-task models
(Section 3.2) with state-of-the-art BioNER systems (reported for each
dataset) and three neural network models from Crichton et al., Lample
et al.; Habibi et al., and Ma and Hovy. The evaluation metrics include
precision, recall and F1 score (Tsai et al., 2006) (Table 2). We denote
results of the best system priorly reported for each dataset as “Dataset
Benchmark". For method proposed by Crichton et al., we quote their
experiment results directly. For other neural network models, we repeart
each experiment three times with the mean and standard deviation reported
(Table 2). To directly compare with the results in Crichton et al., we
measure statistical significance with the same t-test as used in their paper.
We observe that the MTM-CW model achieves significantly higher
F1 scores than state-of-the-art benchmark systems (column Dataset
Benchmark in Table 2) on all of the five datasets. Following established
practice in the literature, we use exact match to compare benchmark
performance on all the datasets except for the BC2GM, where we report
benchmark performance based on alternative match. Furthermore, MTM-
CW generally achieves significantly higher F1 scores than other neural
network models. These results show that the proposed multi-task learning
neural network significantly outperforms state-of-the-art systems and other
neural networks. In particular, the MTM-CW model consistently achieves
a better performance than the single task model, demonstrating that multi-
task learning is able to successfully leverage information across different
datasets and mutually enhance performance on each single task. We further
investigate the performance of three multi-task models (MTM-C, MTM-W,
and MTM-CW, Table 3). Results show that the best performing multi-
task model is MTM-CW, indicating the importance of morphological
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Table 3. F1 scores of three multi-task models proposed in this paper. Bold:
best scores, *: significantly worse than the MTM-CW model (p ≤ 0.05), **:
significantly worse than the MTM-CW model (p ≤ 0.01).
Dataset MTM-C MTM-W MTM-CW
BC2GM 77.80±0.30∗∗ 79.42±0.08∗∗ 80.74±0.04
BC4CHEMD 88.16±0.07∗ 88.49±0.03∗ 89.37±0.07
BC5CDR 86.05±0.26∗∗ 88.26±0.05∗ 88.78±0.12
NCBI-Disease 82.94±0.31∗∗ 84.81±0.14 86.14±0.31
JNLPBA 71.79±0.41∗∗ 73.21±0.16 73.52±0.03
Fig. 4. Macro-averaged F1 scores of the proposed multi-task model compared with
benchmark on different entities. Benchmark refers to the performance of state-of-the-art
BioNER systems.
information captured by character-level BiLSTM as well as lexical and
contextual information captured by word-level BiLSTM.
5.2 Performance on major biomedical entity types
We also conduct more fine-grained comparison of all models on four
major biomedical entity types: genes/proteins, chemicals, diseases and cell
lines since they are the most often annotated entity types (Fig. 4). Each
entity type comes from multiple datasets: genes/proteins from BC2GM
and JNLPBA, chemicals from BC4CHEMD and BC5CDR, diseases from
BC5CDR and NCBI-Disease, and cell lines from JNLPBA.
The MTM-CW model performs consistently better than the neural
network model (Habibi et al., 2017) on all four entity types. It also
outperforms the state-of-the-art systems (Benchmark in Fig. 4) on three
entity types except for cell lines. These results further confirm that
the multi-task neural network model achieves a significantly better
performance compared with state-of-art systems and other neural network
models for BioNER.
5.3 Integration of biomedical entity dictionaries
A biomedical entity dictionary is a manually-curated list of entity names
that belong to a specific entity type. Traditional BioNER systems make
heavy use of these dictionaries in addition to other data. To study whether
our approach can benefit from the use of entity dictionaries, we retrieve
biomedical entity dictionaries for three entity types (i.e., genes/proteins,
chemicals and diseases) from the Comparative Toxicogenomics Database
(CTD) (Davis et al., 2017). We use these entity dictionaries in a neural
network model in two different ways: (1) dictionary post-processing to
match the ‘O’-labeled entities with the dictionary to reduce the false
negative rate, or (2) dictionary feature to provide additional information
about words into the word-level BiLSTM. This dictionary feature indicates
whether a word sequence consisting of a word and its neighbors is present in
a dictionary. We consider word sequences of up to six words, which adds 21
additional dimensions for each entity type. We compare the performance
of MTM-CW with and without adding dictionaries (Table 4).
Table 4. F1 scores of the proposed multi-task model using the CTD entity
dictionary. Bold: best scores, *: significantly worse than the MTM-CW model
(p ≤ 0.05), **: significantly worse than the MTM-CW model (p ≤ 0.01).
Dataset MTM-CW +Dictionary
Feature
+Dictionary
Post-process
BC2GM 80.74±0.04 80.70±0.06 61.56±0.07∗∗
BC4CHEMD 89.37±0.07 88.92±0.10 83.83±0.09∗∗
BC5CDR 88.78±0.12 88.82±0.17 87.90±0.06∗∗
NCBI-Disease 86.14±0.31 85.48±0.44 83.80±0.06∗
JNLPBA 73.52±0.03 73.35±0.30 63.62±0.08∗∗
We observe no significant performance improvement when biomedical
entity dictionaries are included into the MTM-CW model at the pre-
processing stage. Moreover, including dictionaries at the post-processing
stage even hurts the performance. This is presumably due to a higher false
positive rate introduced by the dictionaries, when some words share the
surface name with dictionary entities but do not share the same meaning or
entity types. These results indicate that our multi-task model, by sharing
information at both the character and word levels, is able to learn effective
data representations and generalize to new data without the use of external
lexicon resources.
5.4 Comparison on training time
All of the neural network models are trained on one GeForce GTX 1080
GPU. We compare the average training time (seconds per sentence) of our
method on the 5 main datasets with the baseline neural models in Table 2.
Since our multi-task model requires training on the 5 datasets together, we
calculate and compare the average training time on all datasets instead of on
each individual one. We find that our single-task neural model STM is the
most efficient among the neural models and almost halves the training time
(0.71 s/sent.) when compared to Lample et al.; Habibi et al. (1.59 s/sent.).
Compared to the single-task model STM, our multi-task model MTM-CW
achieves 8.0% overall F1 improvements with only 5.1% additional training
time. The reason that MTM-CW is slightly slower compared with STM is
that it takes a few more epochs for MTM-CW to reach convergence when
trained on 5 datasets together.
5.5 Case study
To investigate the major advantages of the multi-task models compared
with the single task models, we examine some sentences with predicted
labels (Table 5). The true labels and the predicted labels of each model are
underlined in a sentence.
One major challenge of BioNER is to recognize a long entity with
integrity. In Case 1, the true gene entity is “endo-beta-1,4-glucanase-
encoding genes”. The single-task model tends to break this whole entity
into two parts separated by a comma, while the multi-task model can
detect this gene entity as a whole. This result could due to the co-training
of multiple datasets containing long entity training examples. Another
challenge is to detect the correct boundaries of biomedical entities. In
Case 2, the correct protein entity is “SMase” in the phrase “SMase -
sphingomyelin complex structure”. The single-task models recognize the
whole phrase as a protein entity. Our multi-task model is able to detect the
correct right boundary of the protein entity, probably also due to seeing
more examples from other datasets which may contain “sphingomyelin”
as a non-chemical entity. In Case 3, the adjective words “human” and
“complement factor” in front of “H deficiency” should be included as part
of the true entity. The single-task models missed the adjective words while
the multi-task model is able to detect the correct right boundary of the
disease entity. In summary, the multi-task model works better at dealing
with two critical challenges for BioNER: (1) recognizing long entities
with integrity and (2) detecting the correct left and right boundaries of
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Table 5. Case study of the prediction results from different models. The true labels and the predicted labels of each model are underlined in the sentence. A brief
summary of the error type is also included at the end of each example.
Genes/Proteins
Case 1
True label This fragment contains two complete endo - beta - 1, 4 - glucanase - encoding genes, designated celCCC and celCCG.
Habibi This fragment contains two complete endo - beta - 1, 4 - glucanase - encoding genes, designated celCCC and celCCG.
STM This fragment contains two complete endo - beta - 1, 4 - glucanase - encoding genes, designated celCCC and celCCG.
MTM-CW This fragment contains two complete endo - beta - 1, 4 - glucanase - encoding genes, designated celCCC and celCCG.
Error Entity integrity: break a long entity into parts and lose the entity integrity.
Case 2
True label A model for the SMase - sphingomyelin complex structure was built to investigate how the SMase specifically recognizes its substrate.
Habibi A model for the SMase - sphingomyelin complex structure was built to investigate how the SMase specifically recognizes its substrate.
STM A model for the SMase - sphingomyelin complex structure was built to investigate how the SMase specifically recognizes its substrate.
MTM-CW A model for the SMase - sphingomyelin complex structure was built to investigate how the SMase specifically recognizes its substrate.
Error Right boundary error: false detection of non-entity tokens as part of the true entity.
Diseases
Case 3
True label ... human complement factor H deficiency associated with hemolytic uremic syndrome.
Habibi ...human complement factor H deficiency associated with hemolytic uremic syndrome.
STM ... human complement factor H deficiency associated with hemolytic uremic syndrome.
MTM-CW ... human complement factor H deficiency associated with hemolytic uremic syndrome.
Error Left boundary error: fail to detect the correct left boundary of the true entity due to some adjective words in front.
biomedical entities. Both improvements come from collectively training
multiple datasets with different entity types and sharing useful information
between datasets.
6 Conclusion
We proposed an neural multi-task learning approach for biomedical
named entity recognition. The proposed approach, despite being simple
and not requiring manual feature engineering, outperformed state-of-the-
art systems and several strong neural network models on benchmark
BioNER datasets. We also showed through detailed analysis that the strong
performance is achieved by the multi-task model with only marginally
added training time, and confirmed that the large performance gains of our
approach mainly come from sharing character- and word-level information
between biomedical entity types.
Lastly, we highlight several future directions to improve the multi-task
BioNER model. First, combining single-task and multi-task models might
be a fruitful direction. Second, by further resolving the entity boundary
and type conflict problem, we could build a unified system for recognizing
multiple types of biomedical entities with high performance and efficiency.
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